Breaking News, Promotions & Moves

PMI BioPharma Rebrands to August Bioservices

Closes investment from Oak HC/FT to accelerate growth; Jenn Adams named chief executive officer.

By: Contract Pharma

Contract Pharma Staff

PMI BioPharma Solutions, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and manufacturing services, has received funding from Oak HC/FT to expand its capabilities to become a specialized, one-stop-shop CDMO for clinical and commercial injectable therapies. PMI also unveiled its rebranding to August Bioservices and has augmented the company’s expertise with the appointment of several industry executives to its leadership team. The new funding a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters